Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07221604

The Agenda-Setting for Kidney Disease Open Pilot Trial

The goal of this open pilot is to practice using an intervention and surveys before a larger pilot stepped wedge clinical trial. The intervention the researchers plan to use is Chronic Kidney Disease (CKD) Topics, and it is a structured clinical agenda-setting intervention (SAS), or a customized list of discussion topics. The people the researchers are practicing using the SAS with have advanced CKD (stages 4-5), and many of them live in rural areas. The researchers will practice administering CKD Topics, along with survey questions. By doing the open pilot, the researchers will learn if they need to modify the steps they plan to take in the larger trial.

The main questions the researchers aim to answer are:

* Do the steps for identifying eligible participants work? * Do the steps for administering CKD Topics work? * Do the steps to administer survey questions work?

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cheshire Medical Center/Dartmouth-Hitchcock, Keene, New Hampshire, United States

Loading trial locations.

About this study

In this open pilot, the researchers will administer a novel structured agenda-setting tool (SAS) called Chronic Kidney Disease (CKD) Topics. The researchers will determine if their procedures for screening eligible participants, administering the intervention, and administering outcome and other questionnaires are appropriate. Learnings from the open pilot will feed forward into procedures in a larger planned pilot stepped wedge feasibility trial.

This study only has one arm, the intervention arm. The intervention, CKD Topics, will be administered as a quality improvement intervention.

Future Directions: This open pilot will inform procedural changes in an upcoming pilot stepped wedge feasibility trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults >18 years old who have been diagnosed with advanced CKD (stages 4-5).
  • Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent
  • English-speaking
  • Able to provide informed consent
  • Patient must be attending outpatient visits *(in-person and/or telehealth allowable).

Exclusion criteria

  • Children under 18 years old will not be included
  • Non-English-speaking patients and/or care partners
  • Patients on dialysis
  • Individuals unable or unwilling to provide informed consent

Treatment and study plan

Chronic Kidney Disease Structured Agenda-Setting Tool

Behavioral

Chronic Kidney Disease (CKD) Topics is a novel clinical visit agenda-setting intervention developed through participatory research methods for people with CKD living in rural areas. CKD Topics includes 8 structured discussion topic areas with the option for patients to consider and indicate their priority topic areas and take notes before, during, and after a clinical visit.

Primary outcomes

  1. Primary Feasibility Outcome: Intervention receipt

    Time frame: Day 1

    Our primary outcome will be feasibility, assessed by the proportion of patients who received the intervention.

Other outcomes

  1. Primary Process Outcome: Enrollment Rate

    Time frame: Day 1

    As measured by participant enrollment in Redcap.

  2. Preliminary Efficacy Outcome: Patient Self-Advocacy Scale (PSAS)

    Time frame: Day 1

    Patient Self-Advocacy Scale (PSAS); a 12-item validated scale assessing the latent construct of perceived self-advocacy for patients.

  3. Preliminary Efficacy Outcome: Patient self-efficacy

    Time frame: Day 1

    Patient self-efficacy measured using the Ask, Understand, Remember Assessment, (AURA); a validated 4-item assessment of self-efficacy completed by patients.

  4. Preliminary Efficacy Outcome: Patient self-management

    Time frame: Day 1

    Patient demonstration of self-management using the Perceived Medical Condition Self-Management Scale; an 8-item instrument validated to assess self-management among CKD patients; correlated with treatment adherence.

  5. Preliminary Efficacy Outcome: Perceived Efficacy in Patient-Physician Interactions (PEPPI) scale

    Time frame: Day 1

    The 10-item version, PEPPI is a valid and reliable measure of older patients' perceived self-efficacy in interacting with physicians. This instrument may be useful in measuring the impact of empowerment interventions to increase older patients' personal sense of effectiveness in obtaining needed health care

  6. Preliminary Efficacy Outcome: Serious Illness Experience

    Time frame: Day 1

    Serious illness experience measured by the consideRATE questions; a validated 8-item, plain language (2nd grade) patient-reported experience measure (PREM) with Likert-like response options for patients, and care partners.

  7. Preliminary Efficacy Outcome: Respect Experience Assessment

    Time frame: Day 1

    Respect experience assessment measured by the "Heard and understood" tool. Heard and Understood is a validated Single-item PREM with Likert-like response options for patients.

Study contacts

Contact information is provided by the study sponsor or research team.

Anne E. Dade, Research Associate, MPP

CONTACT

[email protected]

Catherine H. Saunders, Assistant Professor of Medicine and of Health Policy, PhD, MPH

CONTACT

[email protected]

603-653-3436

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Collaborators

  • Dartmouth College
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institutes of Health (NIH)

Registry information

Official study title

Setting the Agenda: An Open Pilot of a Structured Clinical Visit Agenda-Setting Intervention for Rural-Residing People With Advanced Chronic Kidney Disease

Acronym: ASK

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Oct 28, 2025
Registry last updated
Jul 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.